Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EPHB2 |
| Upstream (Parents) |
|---|
| (<<) ST14 → EPHB2 |
| (<<) MYB → EPHB2 |
| (<<) MLLT3 → EPHB2 |
| (<<) GTF2IRD1 → EPHB2 |
| Downstream (Children) |
|---|
| EPHB2 → MAP7D3 (>>) |
| EPHB2 → PDGFA (>>) |
| EPHB2 → GPR172A (>>) |
| EPHB2 → PTK7 (>>) |
| EPHB2 → LRFN4 (>>) |
| EPHB2 → LRP4 (>>) |
| EPHB2 → SLC26A6///CELSR3 (>>) |
| EPHB2 → MLLT3 (>>) |
| EPHB2 → DCAF13 (>>) |
| EPHB2 → SLC39A2 (>>) |
| EPHB2 → FAM105A (>>) |
| EPHB2 → CENPJ (>>) |
| EPHB2 → ACO2 (>>) |
| EPHB2 → DUSP8 (>>) |
| EPHB2 → CCNT1 (>>) |
| EPHB2 → PLEKHA8///PLEKHA9 (>>) |
| EPHB2 → ARHGAP10 (>>) |
| EPHB2 → GPR153 (>>) |
| EPHB2 → SEMA3A (>>) |
